Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

Overview of attention for article published in RMD Open, July 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 3 news outlets

twitter: 4 X users

Readers on

mendeley: 3 Mendeley

Summary News X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 4,798 followers.

RT @bmj_rmdopen: 🔔 bDMARD use influences the impact of major adverse iCVE events in #RA. ❤️ 26,534 patient-years, 239 MACE, 362 iCVE ➡️ DA…

10 Aug 2024

Reply Repost Favourite

RT @bmj_rmdopen: 🔔 bDMARD use influences the impact of major adverse iCVE events in #RA. ❤️ 26,534 patient-years, 239 MACE, 362 iCVE ➡️ DA…

09 Aug 2024

Reply Repost Favourite

RT @bmj_rmdopen: 🔔 bDMARD use influences the impact of major adverse iCVE events in #RA. ❤️ 26,534 patient-years, 239 MACE, 362 iCVE ➡️ DA…

09 Aug 2024

Reply Repost Favourite

🔔 bDMARD use influences the impact of major adverse iCVE events in #RA. ❤️ 26,534 patient-years, 239 MACE, 362 iCVE ➡️ DAS28-CRP linked to MACE risk in bDMARD non-users (HR 1.21) 💡 bDMARDs may reduce CV risk in RA. ⛓️ https://t.co/qdw4dDqD5Q @AKarpouzas

09 Aug 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.